Mitral valve repair system to percutaneously treat moderate to severe regurgitation using alfieri edge-to-edge technique - the medfree® valve repair system will innovatively improve upon the current…

Ended Project Grant Awarded Last action

Award ID
R44HL147825
Recipient
Awarding agency
Obligated
$5,306,372

Award facts

Assistance listing
93.837 Cardiovascular Diseases Research
Completion date
Originally
Funding
  • $3,972,174.00 Federal
  • $1,334,198.00 Non-federal
Place of performance
Fremont, CA 94539, USA

Award details come from USAspending.gov.

Description

As the agency reported it.

Mitral valve repair system to percutaneously treat moderate to severe regurgitation using alfieri edge-to-edge technique - the medfree® valve repair system will innovatively improve upon the current market leading mitraclip device, while leveraging and building on the proven percutaneous alfieri edge-to-edge repair technique. We aim to address this vastly unmet percutaneous structural heart market by delivering a simpler, easier-to-use device in a smaller 12 FR catheter system that can be used by a single operator.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $651,889 $0
Amendment $651,889 $0
Amendment $2,500 $0
Amendment $2,500 $2,500
Amendment $1,331,698 $0
Original award $1,331,698 $1,331,698

Quick answers

Who received award R44HL147825?

R44HL147825 was awarded to Medfree Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on January 2, 2020.

How much is award R44HL147825 worth?

$5,306,372 has been obligated on R44HL147825: $3,972,174 in federal funding and $1,334,198 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login